Clincosm LogoSign in Get a demo

COVID-19 and Rhino-orbital Mucormycosis

Sponsor
Minia University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05212961
Collaborator
(none)
40
Enrollment
1
Location
9.6
Anticipated Duration (Months)
4.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Detect the clinical presentation and outcome of post covid-19 fungal mucormycosis in patients referred to Minia university Hospital.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Clinical Profile and Outcome of Post Covid-19 Rhino-orbital Fungal Mucormycosis in Minia Governorate
    Actual Study Start Date :
    Dec 28, 2021
    Anticipated Primary Completion Date :
    Sep 28, 2022
    Anticipated Study Completion Date :
    Oct 15, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Outcome of rhino-orbital mucormycosis in COVID-19 patients [9 months]

      Data of the patients who had post Covid-19 fungal mucormycosis in the last year will be revised to detect clinical presentation and final outcome

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1. Patients who had positive PCR test for Covid-19.

    2. Fungal rhino-orbital infection was confirmed.

    Exclusion Criteria:

    1. Suspected patient with COVID-19 not confirmed with PCR

    2. Incomplete data

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Medicine- Minia University Minya Egypt 61111

    Sponsors and Collaborators

    • Minia University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sahar T A Abdelaziz, Assistant Professor, Minia University
    ClinicalTrials.gov Identifier:
    NCT05212961
    Other Study ID Numbers:
    • Ophthalmology
    First Posted:
    Jan 28, 2022
    Last Update Posted:
    Aug 8, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Mucormycosis
    Zygomycosis

    Study Results

    No Results Posted as of Aug 8, 2022